Celemics, Inc. (KOSDAQ:331920)
10,290
-60 (-0.58%)
At close: Jul 20, 2026
Celemics Market Cap
Celemics has a market cap or net worth of 109.58 billion as of July 21, 2026. Its market cap has increased by 309.83% in one year.
Market Cap
109.58B
Enterprise Value
104.08B
Revenue
4.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,290.00
ChartMarket Cap Chart
Since August 21, 2020, Celemics's market cap has decreased from 200.32B to 109.58B, a decrease of -45.30%. That is a compound annual growth rate of -9.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 115.06B | 419.08% |
| Dec 30, 2025 | 22.17B | -17.10% |
| Dec 30, 2024 | 26.74B | -22.58% |
| Dec 28, 2023 | 34.53B | -27.07% |
| Dec 29, 2022 | 47.35B | -62.21% |
| Dec 30, 2021 | 125.32B | -42.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curiox Biosystems | 707.91B |
| Biodyne | 248.83B |
| M.I.TECH Co.,Ltd | 156.00B |
| Synergy Innovation | 146.79B |
| RecensMedical | 131.07B |
| BIOBIJOU | 94.78B |
| Corentec | 53.63B |
| DENTIS CO.,Ltd | 40.00B |